The stock of Biomea Fusion Inc (NASDAQ: BMEA) has increased by 2.20 when compared to last closing price of 1.59.Despite this, the company has seen a loss of -6.07% in its stock price over the last five trading days. zacks.com reported 2025-04-02 that Biomea Fusion (BMEA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Is It Worth Investing in Biomea Fusion Inc (NASDAQ: BMEA) Right Now?
Additionally, the 36-month beta value for BMEA is 0.08. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 3 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for BMEA is 32.80M and currently, short sellers hold a 31.91% ratio of that float. The average trading volume of BMEA on April 17, 2025 was 634.46K shares.
BMEA’s Market Performance
BMEA stock saw a decrease of -6.07% in the past week, with a monthly decline of -40.48% and a quarterly a decrease of -59.98%. The volatility ratio for the week is 12.27%, and the volatility levels for the last 30 days are 12.96% for Biomea Fusion Inc (BMEA). The simple moving average for the past 20 days is -21.87% for BMEA’s stock, with a -71.73% simple moving average for the past 200 days.
Analysts’ Opinion of BMEA
Many brokerage firms have already submitted their reports for BMEA stocks, with Edward Jones repeating the rating for BMEA by listing it as a “Buy.” The predicted price for BMEA in the upcoming period, according to Edward Jones is $128 based on the research report published on October 09, 2024 of the previous year 2024.
Truist, on the other hand, stated in their research note that they expect to see BMEA reach a price target of $54. The rating they have provided for BMEA stocks is “Buy” according to the report published on September 27th, 2024.
Rodman & Renshaw gave a rating of “Buy” to BMEA, setting the target price at $18 in the report published on September 27th of the previous year.
BMEA Trading at -39.13% from the 50-Day Moving Average
After a stumble in the market that brought BMEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.90% of loss for the given period.
Volatility was left at 12.96%, however, over the last 30 days, the volatility rate increased by 12.27%, as shares sank -41.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -60.94% lower at present.
During the last 5 trading sessions, BMEA fell by -6.07%, which changed the moving average for the period of 200-days by -63.24% in comparison to the 20-day moving average, which settled at $2.0803. In addition, Biomea Fusion Inc saw -58.12% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BMEA starting from Hitchcock Michael J.M., who purchase 10,000 shares at the price of $10.06 back on Sep 30 ’24. After this action, Hitchcock Michael J.M. now owns 15,000 shares of Biomea Fusion Inc, valued at $100,600 using the latest closing price.
Valle Franco, the Chief Financial Officer of Biomea Fusion Inc, purchase 12,509 shares at $4.43 during a trade that took place back on Jun 11 ’24, which means that Valle Franco is holding 42,500 shares at $55,361 based on the most recent closing price.
Stock Fundamentals for BMEA
The total capital return value is set at -2.47. Equity return is now at value -125.38, with -98.92 for asset returns.
Based on Biomea Fusion Inc (BMEA), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -13.67.
Currently, EBITDA for the company is -144.07 million with net debt to EBITDA at 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.15.
Conclusion
In conclusion, Biomea Fusion Inc (BMEA) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
